Akili Grabs CE Mark for Children’s Digital ADHD Treatment Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter The FDA last week cleared EndeavorRx for marketing in the U.S. Source: Devices & Diagnostics Letter You Might Also Like Keytruda Approved in China for Esophageal Squamous Cell Carcinoma June 22, 2020 Gilead Sciences Gears Up for Clinical Trials of Inhaled Remdesivir June 22, 2020 Syncing FDA-CMS Decisions Elusive for Now, Official Says April 7, 2016
